Antisense oligonucleotides (ASOs) represent a pivotal advancement in molecular medicine, offering a powerful tool for modulating gene expression with precision and specificity. Through targeted intervention in genetic pathways, ASOs provide a therapeutic strategy for a myriad of diseases that were previously considered intractable at the genetic level. The design of ASOs involves a sophisticated array of strategies, each tailored to maximize efficacy, specificity, stability, and safety, and minimize off-target effects and toxicity.

Stay curious, stay innovative. I'm Luke McLaughlin.

If you would like to learn more about this topic consider reading our full length articles on biotechnologyreviews.com

Or consider our podcast series on youtube or Spotify at our Biotechnology Reviews Channel.

Our articles are also available on our linkedin newsletter Biotechnology Reviews.

https://www.linkedin.com/pulse/gene-editing-mechanisms-technologies-approaches-luke-mclaughlin-xyy2f/?trackingId=rXAlClfLRnS4KHpWJbjPxg%3D%3D

Ver todos los episodios